- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
FAT10 Antibody / Ubiquitin-Like Modifier Antibody recognizes FAT10, also known as Ubiquitin D (UBD), a ubiquitin-like protein that regulates proteasomal degradation, immune signaling, and inflammatory responses. Unlike ubiquitin, which requires formation of polyubiquitin chains for many of its cellular functions, FAT10 is conjugated directly to substrate proteins through a dedicated enzymatic pathway, targeting them for rapid degradation by the 26S proteasome. This FAT10-dependent modification, known as FAT10ylation, provides an alternative mechanism for controlling protein turnover and maintaining cellular homeostasis. FAT10 Antibody / Ubiquitin-Like Modifier Antibody is widely used to investigate pathways linking inflammation, protein quality control, and immune regulation.
FAT10 expression is normally limited but is strongly induced by the pro-inflammatory cytokines interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α). The protein is most prominently expressed in immune tissues and activated immune cells, where it contributes to antigen processing, innate immune responses, and regulation of inflammatory signaling pathways. FAT10 also interacts with components of the major histocompatibility complex (MHC) and influences protein degradation independently of classical ubiquitination. Through these activities, FAT10 participates in cellular stress responses, apoptosis, and maintenance of protein homeostasis during inflammation and infection. FAT10 Antibody / Ubiquitin-Like Modifier Antibody is therefore valuable for studies of immune activation and cytokine-regulated protein turnover.
Dysregulated FAT10 expression has been associated with numerous pathological conditions including hepatocellular carcinoma, colorectal cancer, gastric cancer, pancreatic cancer, and other malignancies. Elevated FAT10 levels have also been linked to chronic inflammatory disorders, viral infection, metabolic disease, and altered immune responses. Because FAT10 influences cell cycle progression, apoptosis, chromosomal stability, and proteasomal degradation, abnormal expression may contribute to tumor development and disease progression. FAT10 has consequently emerged as both a biomarker and a potential therapeutic target in cancer and inflammation research.
FAT10 Antibody / Ubiquitin-Like Modifier Antibody is a valuable tool for investigations of ubiquitin-like protein modification, proteasomal degradation, immune signaling, inflammation, and cancer biology. Researchers frequently use FAT10 Antibody / Ubiquitin-Like Modifier Antibody to study cytokine-induced signaling, protein quality control, antigen processing, and mechanisms regulating cellular stress responses. Because FAT10 serves as an important mediator linking inflammatory signaling with selective protein degradation, FAT10 Antibody / Ubiquitin-Like Modifier Antibody supports a broad range of studies in immunology, cell biology, and translational disease research.
Explore our Immunology Antibodies page to learn more about proteins that regulate ubiquitin-like modification, antigen processing, and inflammatory immune responses.
Titration of the FAT10 Antibody / Ubiquitin-Like Modifier Antibody may be required due to differences in protocols and secondary/substrate sensitivity.
A portion of amino acids 120-153 from the human protein was used as the immunogen for this FAT10 antibody.
Aliquot the FAT10 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
FAT10 antibody, UBD antibody, Ubiquitin D antibody, Ubiquitin-Like Modifier antibody, FAT10 Protein antibody, HLA-F Adjacent Transcript 10 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.